Screener
Medpace Holdings, Inc. MEDP AVAI — Total Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Medpace Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Medpace Holdings, Inc.’s 10-Q, filed July 23, 2026.
- Filed
- Jul 23, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001668397-26-000025
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Therapeutic Area | ||||
| Metabolic | $219,067 | $147,873 | $456,625 | $295,888 |
| Oncology | 209,372 | 188,558 | 410,611 | 359,034 |
| Other | 98,279 | 118,062 | 191,597 | 213,898 |
| Central Nervous System | 82,858 | 61,129 | 163,065 | 116,030 |
| Cardiology | 59,982 | 58,584 | 116,243 | 116,863 |
| AVAI | 37,773 | 29,105 | 75,794 | 60,168 |
| Total revenue | $707,331 | $603,311 | $1,413,935 | $1,161,881 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Medpace Holdings, Inc.'s AVAI — total revenue?
- Medpace Holdings, Inc. (MEDP) reported AVAI — total revenue of $37.77M in Q2 2026.
- How has Medpace Holdings, Inc.'s AVAI — total revenue changed year-over-year?
- Medpace Holdings, Inc.'s AVAI — total revenue increased by 29.8% year-over-year, from $29.11M to $37.77M.
- What is the long-term trend for Medpace Holdings, Inc.'s AVAI — total revenue?
- Over 4 years (2021 to 2025), Medpace Holdings, Inc.'s AVAI — total revenue has grown at a 5.0% compound annual growth rate (CAGR), from $110.98M to $134.94M.
- What does AVAI — total revenue mean?
- This metric represents the total gross revenue generated specifically from clinical research and development services provided to clients focused on antiviral and anti-infective therapeutic areas. It captures the financial performance of this specialized business unit, reflecting demand for drug development support in infectious disease markets. This revenue stream is a key indicator of the company's market penetration and service delivery success within this specific medical vertical.
Ask your AI about Medpace Holdings, Inc.'s avai — total revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude